ARTICLE | Company News
CellControl Biomedical Laboratories AG, Goodwin deal
February 19, 2002 8:00 AM UTC
Goodwin will manufacture supplies of CellControl’s ACA 125 monoclonal antibody, which is expected to enter Phase I and II trials in the fall for ovarian cancer. ...